title: Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery
source: Yahoo
date: 2025-10-16
url: https://finnhub.io/api/news?id=5e91ffd56eb8dee8c62626bfbf6545f94109b499c566285676c3f4ab496e6cb3
Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, Ph.D., today announced the appointment of Philip R. Kym, Ph.D., as its Head of Drug Discovery. In this newly created role, Dr. Kym will oversee the direction, scientific execution, and operational management of Calico's drug discovery programs, from target identification and validation through lead optimization and candidate selection.
